CRISPR THERAPEUTICS AG
P/S (Price-to-Sales)
Price
Sales Per Share
P/S (Price-to-Sales)
| Fiscal Year | P/S (Price-to-Sales) | Sales Per Share | Price |
|---|---|---|---|
| Dec 2016 | 137.27x | $0.15 | $20.26 |
| Dec 2017 | 23.85x | $0.98 | $23.48 |
| Dec 2018 | 472.71x | $0.06 | $28.57 |
| Dec 2019 | 12.67x | $4.81 | $60.91 |
| Dec 2020 | 15,179.42x | $0.01 | $153.11 |
| Dec 2021 | 6.66x | $11.38 | $75.78 |
| Dec 2022 | 2,638.06x | $0.02 | $40.65 |
| Dec 2023 | 13.36x | $4.69 | $62.60 |
| Dec 2024 | 88.98x | $0.44 | $39.36 |
| Dec 2025 | 1,362.71x | $0.04 | $53.19 |